Similar articles

• Photodynamic treatment (ALA-PDT) suppresses the expression of the oncogenic Bcr-Abl kinase and affects the cytoskeleton organization in K562 cells.

  Pluskalová M, Peslová G, Grebenová D, Halada P, Hrkal Z. Pluskalová M, et al. J Photochem Photobiol B. 2006 Jun 1;83(3):205-12. doi: 10.1016/j.jphotobiol.2006.01.003. Epub 2006 Feb 21. J Photochem Photobiol B. 2006. PMID: 16495075
• The tyrosine phosphatase TC48 interacts with and inactivates the oncogenic fusion protein BCR-Abl but not cellular Abl.

  Mitra A, Sasikumar K, Parthasaradhi BV, Radha V. Mitra A, et al. Biochim Biophys Acta. 2013 Jan;1832(1):275-84. doi: 10.1016/j.bbadis.2012.10.014. Epub 2012 Oct 31. Biochim Biophys Acta. 2013. PMID: 23124138
• [Effects of specific siRNA targeting at bcr-abl fusion gene and its combination with p27 gene clone on chronic myeloid leukemia cell line K562].

  Wang W, DU Y, Lin GQ, Li NN, Sun BZ. Wang W, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Jun;18(3):606-11. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010. PMID: 20561411 Chinese.
• BCR gene expression blocks Bcr-Abl induced pathogenicity in a mouse model.

  Lin F, Monaco G, Sun T, Liu J, Lin H, Stephens C, Belmont J, Arlinghaus RB. Lin F, et al. Oncogene. 2001 Apr 5;20(15):1873-81. doi: 10.1038/sj.onc.1204409. Oncogene. 2001. PMID: 11313935
• [Construction of genetically modified dendritic cell vaccine expressing bcr/abl fusion gene and inducing specific cytotoxic T lymphocytes to kill K562 cells in vitro].

  Wang WW, Huang RW, Hu Y, Li XD, Wang DN, He Y, Liu JJ. Wang WW, et al. Ai Zheng. 2009 Jun;28(6):602-6. Ai Zheng. 2009. PMID: 19635197 Chinese.